|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||251.17 - 253.55|
|52 Week Range||186.00 - 259.01|
|PE Ratio (TTM)||22.26|
|Earnings Date||Oct 15, 2018 - Oct 19, 2018|
|Forward Dividend & Yield||3.60 (1.44%)|
|1y Target Est||283.70|
UnitedHealth Group CEO David Wichmann told investors he wasn't satisfied with the company's quarterly results--not because of slightly higher medical costs--but because he thinks the company needs to be more agile in meeting members' demands for better...
As the initial wave of healthcare companies unveil quarterly results, here are three takeaways from earnings calls. 1. Drugmakers are rethinking pricing strategies After Pfizer Inc. earlier this month said it would defer price hikes, Novartis AG said Wednesday, July 18, it will not raise prices for the rest of the year.
A new spin on an old drug could dent demand for Epidiolex, a marijuana-based epilepsy drug. Plus, here's how important Medicare and Medicaid are to UnitedHealth Group's profits.
UnitedHealth delivered an earnings beat, but its shares fell. Johnson & Johnson's stock took a strong jump on earnings, despite recent bad news from a jury.
By all rational measures, United Health (NYSE:UNH) produced a very solid performance for its second quarter fiscal 2018 earnings report. The country’s biggest health-insurance provider exceeded profitability expectations, while meeting the consensus target for revenues. While the “paper stats” were impressive – United Health hit an earnings per share of $3.14, up 3.2% from the $3.04 consensus target – Barron’s Teresa Rivas notes that much of the positive surprise boils down to non-operating factors.
MARKET PULSE A policy being weighed by the Trump administration that could threaten drug price rebates, a widespread feature of the U.S. pharmaceutical system that largely benefits pharmaceutical middlemen, sent shares of those companies down in Thursday trade.
On Wednesday, there were murmurs that an activist investor might get involved in the Cigna (CI)/Express Scripts Holding (ESRX) merger, in which the health insurer plans to buy the pharmacy-benefits manager in a deal worth $54 billion. Leerink's Ana Gupte wades into the world of health-care mega-mergers today, noting that along with Cigna, UnitedHealth Group (UNH) also closed higher on the news yesterday. Gupte argues that while Amazon and Walmart may be able to "enter or deepen" their presence in the drug supply chain, "they would not be able to compete with sophisticated managed care companies such as UnitedHealth, Humana [HUM] and increasingly Anthem [ANTM] on integrated care delivery with coverage absent a substantial MCO acquisition." That said, she writes that Amazon or Walmart could facilitate cross-selling into prescription-drug benefits and increase store traffic by striking a deal with a managed-care organization.
Wall Street's just dinged two of them and rewarded the third -- but Motley Fool analysts take a longer view.
UnitedHealth Group Inc. is among the companies interested in buying Conifer, the health-management unit of Tenet Healthcare Corp., in what could be a deal worth $2 billion or more.
U.S. stock futures pointed lower on Thursday, July 19, and global shares traded mostly to the downside as trade war concerns held down gains. Data from Japan on Thursday illustrated the broader trade war concerns, with exports from the world's third-largest economy to the United States falling 0.9% in June - the first decline in 17 months - even as the country's trade surplus swelled to $5.24 billion thanks to slowing imports of American-made goods. U.S. companies, as well, have begun questioning the impact of Donald Trump's trade policies, according to the Federal Reserve's "Beige Book" survey of regional business sentiment for June.
LONDON, UK / ACCESSWIRE / July 19, 2018 / If you want access to our free earnings report on UnitedHealth Group Inc. (NYSE: UNH) ("UNH"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=UNH. The Company reported its financial results on July 17, 2018, for the second quarter of the fiscal year 2018, ended June 30, 2018. For Q2 FY18, the Company’s revenues were in-line with analysts’ consensus estimates, while its earnings surpassed forecasts.
The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - The European Union hit Alphabet Inc's Google with a record ...
healthcare management subsidiary Conifer in a deal that could be valued at $2 billion, according to published reports. A story in the online edition of The Wall Street Journal citing people familiar with the matter reported late Wednesday that it's not known who the other potential suitors are for Conifer, a business which accounted for 8% of Tenet's revenue last year. The report also noted there's no certainty UnitedHealth will make a deal for Conifer, and that Tenet may not sell the business.
UnitedHealth Group Inc. is among suitors exploring an acquisition of Tenet Healthcare Corp.’s health-care-management subsidiary, according to people familiar with the matter, as the industry giant pursues further expansion. Tenet, one of the largest U.S. hospital companies, has said it would weigh a sale of the unit, Conifer Health Solutions, which provides services to hospitals and physician groups. Tenet said it would make a decision in the first half of 2018 on Conifer, which accounted for about 8% of its revenue last year.
The Dow Jones Industrial Average late-morning Wednesday was trading near its highest level of the session, with its gains powered by UnitedHealth Group Inc. (UNH) and Boeing Co. (BA) Shares of the UnitedHealth and Boeing were contributing a combined 54 points to the price-weighted Dow (DJIA) The benchmark most recently was up about 40 points, or 0.2%, at 25,159, trading near session highs. UnitedHealth's shares were up about $4.19, or 1.7%, while those for industrial giant Boeing were climbing by $3.88 or more than 1%. A $1 move in any one of the Dow's components translates to a roughly 6.8-point swing in the equity gauge.
UnitedHealth Group Inc. on Tuesday raised its full-year earnings outlook as the company continued to see growth in health plan membership and premiums. On an adjusted basis, UnitedHealth’s profit rose to $3.14 a share. Analyst polled by Thomson Reuters were expecting $3.04 a share.